New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease

Type 2 diabetes mellitus (T2DM) greatly increases risk for cardiovascular disease, including ischemic heart disease and myocardial infarction. With the completion of several cardiovascular outcomes trials (CVOTs) for new glucose-lowering therapies, including the sodium-glucose cotransporter-2 (SGLT2...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Malak Almutairi, Jordan S. F. Chan, John R. Ussher
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2022-06-01
Цуврал:	Frontiers in Physiology
Нөхцлүүд:	type 2 diabetes mellitus glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors ischemic heart disease myocardial infarction
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphys.2022.904626/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!